Social Media Competition Rules

Breast International Group-aisbl, with its legal address at rue de Bretagne 20, 1200 Brussels, Belgium (hereinafter “BIG”). The Breast International Group (BIG) is an international not-for-profit organisation that represents the largest global network of academic research groups dedicated to finding better treatments and cures for breast cancer. Its mission is to facilitate and accelerate breast cancer research at an international level.

BIG against breast cancer a été créé pour collecter des fonds et financer des études cliniques et des programmes de recherche initiés par BIG qui ne présentent pas d’intérêt commercial, mais qui sont essentiels pour les patients.  

BIG against breast cancer is organizing a social media competition (the “Competition”) through a post (the “Post”) shared simultaneously on its social media platforms Facebook and Instagram (collectively, the “Social Media Platforms”).

  1. Eligibility
  • This Competition is open to all individuals aged 18 years or above, that have a personal account on at least one of the Social Media Platforms.
  • To be considered for the Competition, participants must also meet the conditions set out in the Post and participate during the Competition period stated in the Post.
  • Incomplete or incorrect entries will not be considered.

 

  1. Draw

    The winner will be chosen randomly among all of the participants meeting the eligibility criteria. The winner’s username will be announced in the caption of the competition post on Instagram as well as personally contacted by message by BIG against breast cancer on one of the Social Media Platforms and BIG against breast cancer will request additional information. If the winner does not provide this information within 10 working days, another winner will be designated.


  2. Prize
  • The winner will receive the prize specified in the Post.
  • The prize is non-transferable and non-exchangeable for cash or other items.

  1. Disqualification

Will be automatically disqualified from the Competition, participants who:

  • Participate in the Competition via several different accounts on the Social Media Platforms,
  • Violate the Competition rules,
  • Violate the terms of service of the Social Media Platforms, or
  • Are HQ staff members of BIG.

  1. Limitation of Liability
  • BIG against breast cancer will not incur any liability as a result of the organization of this Competition, in particular if, in the event of force majeure or events beyond its control, it is required to cancel, shorten, extend or postpone the Competition.
  • The Competition is in no way sponsored, endorsed or administered by, or associated with, the Social Media Platforms.

  1. Personal Data
  • - Les informations nominatives recueillies dans le cadre de la présente tombola sont traitées conformément à la loi du 30 Juillet 2018 relative à la protection des personnes physiques à l'égard des traitements de données à caractère personnel, ainsi que le règlement no 2016/679, dit règlement général sur la protection des données. Les participants sont informés que les données nominatives les concernant, enregistrées dans le cadre de cette tombola, sont nécessaires à la prise en compte de leur participation.
  • - Les participants bénéficient auprès du BIG against breast cancer d'un droit d'accès, de rectification, d’opposition, droit à l’effacement de ses données, droit à la limitation du traitement de ses données et droit à la portabilité des informations recueillies sur tout document les concernant. L’exercice de ces droits peut être limité par les lois applicables.

    To learn more about how BIG handles personal data, please read its privacy policy or contact its Data Protection Officer at dpo@BIGagainstbc.org.

  1. Disputes

    In the event of a dispute, BIG against breast cancer will rely solely on the jurisdiction of the courts of the judicial district of Brussels.

  2. Adherence to Rules

    Participation in the BIG against breast cancer Competition implies acceptance of these rules.

Done in Brussels, 01.06.2023
Theodora Goulioti, MD
Directrice générale (CEO)